| 000 | 01644 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250516233005.0 | ||
| 264 | 0 | _c20150715 | |
| 008 | 201507s 0 0 eng d | ||
| 022 | _a1473-6527 | ||
| 024 | 7 |
_a10.1097/QCO.0000000000000101 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHolmes, Natasha E | |
| 245 | 0 | 0 |
_aWhat's new in the treatment of serious MRSA infection? _h[electronic resource] |
| 260 |
_bCurrent opinion in infectious diseases _cDec 2014 |
||
| 300 |
_a471-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAcetamides _xadministration & dosage |
| 650 | 0 | 4 | _aAnti-Bacterial Agents |
| 650 | 0 | 4 |
_aCephalosporins _xadministration & dosage |
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 | _aDrug Administration Routes |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aGlycopeptides _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLinezolid |
| 650 | 0 | 4 | _aLipoglycopeptides |
| 650 | 0 | 4 |
_aMethicillin-Resistant Staphylococcus aureus _xdrug effects |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 |
_aOxazolidinones _xadministration & dosage |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 |
_aSkin Diseases, Bacterial _xdrug therapy |
| 650 | 0 | 4 |
_aStaphylococcal Infections _xdrug therapy |
| 650 | 0 | 4 |
_aTetrazoles _xadministration & dosage |
| 650 | 0 | 4 |
_aVancomycin _xadministration & dosage |
| 700 | 1 | _aHowden, Benjamin P | |
| 773 | 0 |
_tCurrent opinion in infectious diseases _gvol. 27 _gno. 6 _gp. 471-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/QCO.0000000000000101 _zAvailable from publisher's website |
| 999 |
_c24181259 _d24181259 |
||